Detomidine
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392205This classification denotes an alpha-adrenergic agonist with the molecular formula C12H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7N8K34P2XH, chemically known as 4-(2,3-dimethylbenzyl)imidazole but generally known as detomidine, which bears US NIH Compound Identifier 56032. European Medicines Agency schedules Detomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07012MIG. The term DETOMIDINE is an International Non-Proprietary Name. DETOMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule detomidine under HS 29332990 and SITC 51573. As of Q4 2014, DETOMIDINE remains the US FDA Preferred Term for this commodity. Detomidine bears US NLM identifiers UMLS ID C0057577 and NCI Concept Code C83664. SMILES: CC1=C(C(=CC=C1)CC2=CN=CN2)C.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.